ARUP Laboratories announced the expansion of its groundbreaking AI-augmented screening tool for the detection of human gastrointestinal parasites to include wet-mount slides. With this expansion, ARUP Laboratories will become the first and only laboratory to apply AI-augmented screening to the entire ova and parasite testing process.
"By utilizing an AI-augmented...
Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, announced the company will build on its recent business development momentum by soliciting Requests-For-Proposal (“RFPs”) for license or sale of its PsyAI™ trademark portfolio as a...
Synergy Laboratories, a leading full-service diagnostic laboratory, has launched Hologic's state-of-the-art Genius™ Digital Diagnostics System with Genius Cervical AI algorithm marking a significant advancement in cervical cancer screening and diagnostics. As the first to introduce this cutting-edge system to the Gulf Coast, Synergy Laboratories is setting a new benchmark for precision medicine,...
Collaboration brings together leading lung and breast imaging expertise to advance AI-driven cancer detection and early intervention.
Optellum, the leader in AI-enabled lung cancer diagnosis, announced it has entered a strategic agreement with Volpara Health, a Lunit company and a global leader in software for the early detection of cancer,...
Groundbreaking intelligence addresses a $1B industry problem, helping healthcare organizations streamline billing workflows and receive accurate reimbursement
DeepScribe, the ambient AI of choice for specialty and chronic care, announced automated Evaluation and Management (E/M) medical coding as the newest offering within its Ambient Operating System for clinicians. Part of DeepScribe Assist insights, E/M...
GenBio AI, a leading company at the intersection of AI and biology, is excited to announce that Dr. Ziv Bar-Joseph has joined as Co-founder and Chief Scientific Officer.
In this role, Bar-Joseph will lead work focused on the integration and use of GenBio AI's multiscale foundation models, ensuring they drive real impact...
The partnership combines Ubie's AI-driven symptom identification and high rates of patient engagement with Nucleus Genomics' cutting-edge complete DNA sequencing
Ubie, a global healthcare AI platform that guides patients to better interactions with providers and life sciences, and Nucleus Genomics, the next-generation genetic testing and analysis company, announced the outcomes of...
Systech, part of Markem-Imaje and Dover and a leading provider of digital identification and traceability software solutions, announced the launch of UniSecure artAI™, a transformative AI-powered authentication solution designed to safeguard brands, ensure packaging quality and protect patients. As a fully cloud-based Software as a Service (SaaS) solution, artAI leverages existing packaging...
The Next platform will analyze clinical data from mBC patients treated in certain centers and notify clinicians when ESR1 testing is missing at disease progression.
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, and the Menarini Group, a leading international pharmaceutical and...
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico Medicine, a clinical stage generative artificial intelligence (AI)-driven biotechnology company, announced a strategic collaboration to accelerate the discovery and development of innovative therapeutic antibodies, leveraging...
